Abstract
To study associations between initiating eslicarbazepine acetate (ESL) vs. brivaracetam (BRV) after switching from generic antiseizure drugs (ASDs) and healthcare resource utilization (HCRU) and charges among patients with treated focal seizures (FS).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
